To assess the possible role of neuropeptide-Y (NPY) on vitiligo development, NPY levels were measured in tissue fluid collected from skin lesions of vitiligo patients (n = 47) and uninvolved skin from healthy controls (n = 32). The gene discussed is NPY; the disease is vitiligo.